A study in the New England Journal of Medicine explores the cost impact of hospice use by nursing home residents.
The United States’ health system takes a lot of hits for excessive spending compared to outcomes, but in the case of cancer care, our high spending may yield results.
The Evolent IPO filing is a reminder that investing is often not rational.
Bookending the week is another medication item as CMS released detailed data on drug use by Medicare beneficiaries.
The annual Medscape physician compensation report reveals low growth for many of the most common specialties, but family medicine saw a 10% rise.
A recent report examines funding for startup health companies, especially those involved in “digital” health.
A Viewpoint in JAMA summarizes a recent Institute of Medicine report designed to rationalize quality measurement for health systems.
Starting off the week with more medication reports is a summary of the IMS report on drug use in America.
Need all your fingers and toes to count the Medicare “quality” initiatives doctors have to comply with, and many are responding with a certain finger to those programs.
TransUnion Healthcare issued a report on how patients are coping with the ongoing financial pressures related to their health care.